Patient-reported treatment outcomes in ME/CFS and long COVID,
Citation: M. Eckey, P. Li, B. Morrison, J. Bergquist, R.W. Davis, & W. Xiao, Patient-reported treatment outcomes in ME/CFS and long COVID, Proc. Natl. Acad. Sci. U.S.A. 122 (28) e2426874122 (peer-reviewed), https://doi.org/10.1073/pnas.2426874122 (2025).
Key Tollovid Data: A total of 54 Long COVID patients reported taking Tollovid for at least 15 days participated in the study. 54% of patients reported feeling better, with 35% of patients reporting feeling much better. p < 0.0001 (Adjusted p-value when compared to reference group).
Access to the raw data available for download here. Referenced Tollovid data is on line 180.